Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,995 | -10,605 | -7,502 | -4,952 | -2,695 |
| Depreciation Amortization | 258 | 970 | 726 | 489 | 242 |
| Accounts receivable | -123 | -165 | -81 | 164 | -149 |
| Accounts payable and accrued liabilities | -567 | 2,577 | -555 | -792 | 221 |
| Other Working Capital | -577 | -721 | -1,025 | -517 | -78 |
| Other Operating Activity | 1,158 | -1,734 | 970 | 897 | 72 |
| Operating Cash Flow | $-2,847 | $-9,677 | $-7,467 | $-4,712 | $-2,387 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -232 | -23 | -9 | N/A |
| Other Investing Activity | -70 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-70 | $-232 | $-23 | $-9 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,558 | 4,598 | 3,996 | 695 | 43 |
| Other Financing Activity | 0 | 0 | 0 | -21 | 0 |
| Financing Cash Flow | $3,558 | $4,598 | $3,996 | $674 | $43 |
| Exchange Rate Effect | -1 | 27 | -2 | -15 | 30 |
| Beginning Cash Position | 1,020 | 6,304 | 6,304 | 6,304 | 6,304 |
| End Cash Position | 1,660 | 1,020 | 2,807 | 2,242 | 3,989 |
| Net Cash Flow | $640 | $-5,284 | $-3,497 | $-4,062 | $-2,315 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,847 | -9,677 | -7,467 | -4,712 | -2,387 |
| Capital Expenditure | N/A | -232 | -23 | -9 | N/A |
| Free Cash Flow | -2,847 | -9,909 | -7,491 | -4,721 | -2,387 |